Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United States
Summary - Marburg Virus (Marv) And Sudan Virus (Sudv) Vaccines
Deadline - Jul 11, 2025
GT reference number - 112180042
Product classification - Research and development consultancy services
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 112180042
Document Type - Tender Notices
Description - Description: Synopsis This pre-solicitation notice serves as the intent to announce a Request for Proposal (RFP) at a later date for the advanced development, licensure, and procurement of vaccines against Marburg virus (MARV) and Sudan ebolavirus (S UDV). Furthermore, the intended RFP will also support late-stage development and Phase 4 Post-Marketing commitments/requirements required by the Food and Drug Administration (FDA) for products approved under the animal rule. The Filovirus family, which includes Marburg virus (MARV) and the ebolaviruses Ebola virus (EBOV) and Sudan virus (SUDV), are known to cause severe health consequences, including death, in humans. Infections with EBOV, SUDV,
Gt Ref Id - 112180042
Deadline - Jul 11, 2025
Similar Tenders :
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database